1. Home
  2. APLS vs DOCN Comparison

APLS vs DOCN Comparison

Compare APLS & DOCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • DOCN
  • Stock Information
  • Founded
  • APLS 2009
  • DOCN 2011
  • Country
  • APLS United States
  • DOCN United States
  • Employees
  • APLS N/A
  • DOCN N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • DOCN Retail: Computer Software & Peripheral Equipment
  • Sector
  • APLS Health Care
  • DOCN Technology
  • Exchange
  • APLS Nasdaq
  • DOCN Nasdaq
  • Market Cap
  • APLS 3.6B
  • DOCN 3.7B
  • IPO Year
  • APLS 2017
  • DOCN 2021
  • Fundamental
  • Price
  • APLS $27.52
  • DOCN $39.28
  • Analyst Decision
  • APLS Buy
  • DOCN Buy
  • Analyst Count
  • APLS 18
  • DOCN 13
  • Target Price
  • APLS $46.71
  • DOCN $42.67
  • AVG Volume (30 Days)
  • APLS 1.4M
  • DOCN 1.3M
  • Earning Date
  • APLS 02-28-2025
  • DOCN 02-25-2025
  • Dividend Yield
  • APLS N/A
  • DOCN N/A
  • EPS Growth
  • APLS N/A
  • DOCN N/A
  • EPS
  • APLS N/A
  • DOCN 0.87
  • Revenue
  • APLS $715,216,000.00
  • DOCN $756,564,000.00
  • Revenue This Year
  • APLS $97.25
  • DOCN $14.26
  • Revenue Next Year
  • APLS $12.68
  • DOCN $13.04
  • P/E Ratio
  • APLS N/A
  • DOCN $44.98
  • Revenue Growth
  • APLS 162.10
  • DOCN 12.08
  • 52 Week Low
  • APLS $24.34
  • DOCN $26.63
  • 52 Week High
  • APLS $71.90
  • DOCN $47.02
  • Technical
  • Relative Strength Index (RSI)
  • APLS 38.99
  • DOCN 42.11
  • Support Level
  • APLS $26.84
  • DOCN $44.34
  • Resistance Level
  • APLS $28.59
  • DOCN $47.02
  • Average True Range (ATR)
  • APLS 1.12
  • DOCN 1.99
  • MACD
  • APLS -0.03
  • DOCN -0.49
  • Stochastic Oscillator
  • APLS 18.09
  • DOCN 7.47

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About DOCN DigitalOcean Holdings Inc.

DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and Other countries.

Share on Social Networks: